Related Experiment Video

Updated: Dec 19, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.5K

Patient engagement in research on rare gynecological tumors

Joline Roze1, Jolijn Groeneweg2, Glen Monroe2

  • 1Department of Gynaecological Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands J.F.Roze@umcutrecht.nl.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|June 4, 2020
PubMed
Abstract

No abstract available in PubMed .

Keywords:
granulosa cell tumor

More Related Videos

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.4K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.6K

Related Experiment Videos

Last Updated: Dec 19, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.5K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.4K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.6K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K

Articles linked to this work by shared authors, journal, and citation graph.

Macroscopic prediction of cervical dysplasia at colposcopy for see-and-treat patient selection: a systematic review.

European journal of obstetrics, gynecology, and reproductive biology·2026

Gender and regional equity in the European Society of Gynaecological Oncology: a longitudinal analysis of a professional medical society.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Perioperative Risk Stratification in Surgically Treated Endometrial Cancer: The Impact of Nutritional Status and Comorbidity Burden on Morbidity and Survival.

Annals of surgical oncology·2026

High-Risk Human Papillomavirus Clearance with a Coriolus versicolor-Based Vaginal Gel.

Diseases (Basel, Switzerland)·2026

Association of Oral Papivir/Pavirona® Supplementation with HPV DNA Clearance.

Viruses·2026

International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical Screening.

Journal of medical virology·2026

Retrospective evaluation of minimally invasive surgical strategies in ovarian neoplasms (REMISSION study): oncological outcomes.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Enhanced recovery after surgery in minimally invasive hysterectomy for uterine cancer: identifying predictors of same-day discharge.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Vaginal natural orifice transluminal endoscopic surgery versus conventional laparoscopy for sentinel lymph node mapping in early-stage endometrial cancer: a systematic review and meta-analysis.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Incremental risk of high-grade adverse events with immune checkpoint inhibitors with or without poly(adenosine diphosphate-ribose) polymerase inhibitors in first-line treatment of advanced endometrial cancer: a systematic review and meta-analysis.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Inavolisib for PIK3CA-mutated advanced endometrial cancer: a multicentric, phase II, MITO END-4 trial.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Diagnostic accuracy of Chronic Kidney Disease Epidemiology Collaboration 2021 and Janowitz-estimated glomerular filtration rate for identifying renal dysfunction compared with 99mTc-DTPA in patients with locally advanced cervical cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

In vitro and in vivo studies on the impact of the familial adenomatous polyposis heterogeneous mutation MUC20-S671C on colorectal carcinogenesis and progression.

Translational cancer research·2026

Double heterozygous germline pathogenic variants in patients referred to a tertiary cancer genetics clinic in Singapore.

Frontiers in oncology·2026

Correction: Integrative subtyping by bile acid metabolism identifies CLCA1/UGT2A3/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer.

Frontiers in oncology·2026

Deconvolution of evolutionary architecture unmasks a high-risk, subclonal-rich subtype in treatment-naive small cell lung cancer.

Journal of thoracic disease·2026

Overexpression of TCF7L2 promotes the viability and migration of MHCC-97H human hepatocellular carcinoma cells by upregulating MT-ND4L.

Translational cancer research·2026

Metabolic reprogramming in diabetes and cancer: the role of PI3K/AKT/mTOR and beyond.

American journal of cancer research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us